Artwork

Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Therapy In Limbo: The FDA's MDMA Decision & What Went Wrong

24:56
 
Share
 

Manage episode 424437882 series 2813395
Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results.

The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.

Follow Kennedy on Twitter: @KennedyNation

Kennedy Now Available on YouTube: https://bit.ly/4311mhD.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

403 episodes

Artwork
iconShare
 
Manage episode 424437882 series 2813395
Content provided by Fox News Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fox News Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results.

The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.

Follow Kennedy on Twitter: @KennedyNation

Kennedy Now Available on YouTube: https://bit.ly/4311mhD.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

403 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide